Abbisko Therapeutics

Abbisko Therapeutics is a clinical-stage biopharmaceutical company specializing in the discovery and development of innovative small molecule therapies for oncology. Founded in 2016 and based in the Zhangjiang Hi-Tech Park in Shanghai, China, the company leverages a robust in-house R&D engine and a multi-dimensional discovery platform to advance its pipeline of 10 small molecule programs. Abbisko serves the oncology market, targeting unmet medical needs with differentiated therapies. The business model focuses on taking drug candidates from discovery through clinical development and commercialization, generating revenue through partnerships, licensing agreements, and eventual product sales. The company is led by a seasoned management team with extensive experience in drug discovery and development, ensuring a strategic approach to bringing new treatments to market.

Keywords: oncology, small molecule, biopharmaceutical, R&D, clinical-stage, drug discovery, Shanghai, innovative therapies, commercialization, differentiated.